Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Equity Ratio (2020 - 2024)

Historic Equity Ratio for Burning Rock Biotech (BNR) over the last 5 years, with Q4 2024 value amounting to 0.66.

  • Burning Rock Biotech's Equity Ratio fell 1120.39% to 0.66 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.66, marking a year-over-year decrease of 1120.39%. This contributed to the annual value of 0.66 for FY2024, which is 1120.39% down from last year.
  • According to the latest figures from Q4 2024, Burning Rock Biotech's Equity Ratio is 0.66, which was down 1120.39% from 0.74 recorded in Q4 2023.
  • Burning Rock Biotech's Equity Ratio's 5-year high stood at 0.91 during Q2 2020, with a 5-year trough of 0.44 in Q4 2021.
  • In the last 5 years, Burning Rock Biotech's Equity Ratio had a median value of 0.75 in 2022 and averaged 0.76.
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 5169.91% in 2021, then surged by 6617.16% in 2022.
  • Over the past 5 years, Burning Rock Biotech's Equity Ratio (Quarter) stood at 0.91 in 2020, then plummeted by 51.7% to 0.44 in 2021, then soared by 66.17% to 0.73 in 2022, then rose by 1.26% to 0.74 in 2023, then decreased by 11.2% to 0.66 in 2024.
  • Its Equity Ratio was 0.66 in Q4 2024, compared to 0.74 in Q4 2023 and 0.73 in Q4 2022.